Market Research Report
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Philippines
|Published by||GlobalData||Product code||917873|
|Published||Content info||144 Pages
Delivery time: 1-2 business days
|CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Philippines|
|Published: November 29, 2019||Content info: 144 Pages||
GlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Philippines". The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in the Philippines. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of the Philippines. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData's team of industry experts.
The Philippines healthcare market is one of the major emerging markets in the world, with a strong focus on research and development (R&D). The Philippines pharmaceutical market increased from ?128B in 2011 to ?176B in 2018 at a Compound Annual Growth Rate (CAGR) of 4.65%. In terms of US dollars, the pharmaceutical market was $2.96B in 2011, which increased to $3.34B in 2018 at a CAGR of 1.75%. The Philippines medical device market was valued at $196.18M in 2015, which increased to $227.10M in 2018. The Philippines pharmaceutical and medical device market is import-driven.
The report provides information on the healthcare, regulatory, and reimbursement landscape in the Philippines, and includes -
This report will enhance your decision-making capability by allowing you to: